Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

24.38
+0.88003.75%
Volume:23.77K
Turnover:562.62K
Market Cap:403.83M
PE:-1.08
High:25.14
Open:23.45
Low:23.18
Close:23.50
52wk High:26.54
52wk Low:5.23
Shares:16.57M
Float Shares:15.15M
Volume Ratio:0.49
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.4900
EPS(LYR):-22.4900
ROE:-1810.01%
ROA:-23.38%
PB:-3.05
PE(LYR):-1.08

Loading ...

Jun 14, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2023

Major Issues Report

Form 8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 23, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 20, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2022

Major Issues Report

8-K - Current report